George Vlachogiannis: Imaging challenges in malignant pleural mesothelioma
George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared a post on LinkedIn about a paper by Carmine Picone et al. published in Cancer Control:
“Malignant pleural mesothelioma (MPM) poses significant challenges in imaging assessment due to its unique growth pattern.
In this Cancer Control Mini Review, researchers from IRCCS, National Cancer Institute G. Pascale Foundation, Naples, Italy emphasize the importance of mRECIST 1.1, a refined methodology merging mRECIST and RECIST 1.1, to ensure accurate, reliable, and reproducible MPM tumor measurement.
Additionally, the integration of iRECIST criteria enhances response evaluation in immunotherapy trials, addressing challenges like pseudoprogression.
By adopting a standardized imaging approach, clinicians can improve diagnostic accuracy, optimize treatment response evaluation, and advance research in MPM.”
“Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?”
Authors: Carmine Picone, Annamaria Porto, Roberta Fusco, Vincenza Granata, Maria Chiara Brunese, Gianfranco Vallone, Ferdinando Caranci, Raffaella Mormile, Alessandro Morabito, Antonella Petrillo et al.
More posts featuring George Vlachogiannis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023